title: Global fee prohibits postpartum provision of the most effective reversible contraceptives.
authors.affiliation: Office of Population Research, Princeton University, Princeton, NJ, USA. Electronic address: aaiken@princeton.edu.
authors.forename: Abigail R A
authors.initials: AR
authors.lastname: Aiken
authors.affiliation: Department of Obstetrics and Gynecology, University of California, Davis, Sacramento, CA, USA.
authors.forename: Mitchell D
authors.initials: MD
authors.lastname: Creinin
authors.affiliation: Department of Obstetrics and Gynecology, University of Florida College of Medicine-Jacksonville, Jacksonville, FL, USA.
authors.forename: Andrew M
authors.initials: AM
authors.lastname: Kaunitz
authors.affiliation: Department of Obstetrics and Gynecology, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.
authors.forename: Anita L
authors.initials: AL
authors.lastname: Nelson
authors.affiliation: Office of Population Research, Princeton University, Princeton, NJ, USA.
authors.forename: James
authors.initials: J
authors.lastname: Trussell
mesh_terms: D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000191:economics*; D004343:Drug Implants / Q000191:economics*; D005260:Female; D017721:Hospital Costs; D006801:Humans; D007434:Intrauterine Devices / Q000191:economics*; D049590:Postpartum Period
chemical_list: D003271:Contraceptive Agents, Female; D004343:Drug Implants